Alexion Pharmaceuticals, Inc. (ALXN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
127.22-6.47 (-4.84%)
At close: 4:00 PM EDT
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Prev Close133.69
Bid127.22 x 100
Ask127.49 x 100
Day's Range127.18 - 132.30
52wk Range110.56 - 193.45
1y Target EstN/A
Market Cap28.53B
P/E Ratio (ttm)319.65
Avg Vol (3m)1,630,526
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Barrons.comyesterday

    [$$] Biotech Is Cheaper Than Big Pharma

    After years of skyrocketing stock prices fueled by blockbuster drug sales, Big Biotech is now seen by investors as being no better, and perhaps worse, than Big Pharma. You are getting good pipeline assets at a much bigger discount,” says Marshall Gordon, manager of the ClearBridge Global Health Care Innovations fund.

  • Investopediayesterday

    Alexion Gets U.K. Approval for High-Cost Drug (ALXN)

    Though user base is small for this rare disease, the high annual cost of up to $2 million offers attractive commercials for Alexion.

  • Business Wire2 days ago

    Alexion Employees Volunteer Together in Company’s First Global Day of Service

    Alexion Pharmaceuticals, Inc. announced today that more than 1,500 employees around the world are volunteering in their respective communities as part of the Company’s first Global Day of Service.